Virrey, Michelle B.
HRN: 26-48-94 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/01/2026
CEFUROXIME 500MG (TAB)
02/01/2026
02/07/2026
ORAL
500mg
2 Times A Day
Premature Rupture Of Membranes
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes